| 1 | Life expectancy and years of life lost in chronic obstructiv… (10.2147/copd.s5237) | Abstract References ORCID License | 203.34 | 107 |
| 2 | Epidemiology and clinical impact of major comorbidities in p… (10.2147/copd.s49621) | Abstract References ORCID | 186.11 | 302 |
| 3 | Medication adherence issues in patients treated for COPD (10.2147/copd.s3036) | Abstract References ORCID | 185.35 | 295 |
| 4 | Change in inflammation in out-patient COPD patients from sta… (10.2147/copd.s4854) | Abstract References ORCID License | 183.25 | 67 |
| 5 | Particulate matter air pollution exposure: role in the devel… (10.2147/copd.s5098) | Abstract References ORCID | 181.37 | 261 |
| 6 | Oxidative stress and free radicals in COPD – impli… (10.2147/copd.s51226) | Abstract References ORCID | 181.00 | 258 |
| 7 | Major air pollutants and risk of COPD exacerbations: a syste… (10.2147/copd.s122282) | Abstract References ORCID | 178.24 | 237 |
| 8 | Lung function decline in COPD (10.2147/copd.s27480) | Abstract References ORCID | 178.11 | 236 |
| 9 | Pathogenic triad in COPD: oxidative stress, protease&nda… (10.2147/copd.s10770) | Abstract References ORCID | 176.27 | 223 |
| 10 | Disease burden of COPD in China: a systematic review (10.2147/copd.s161555) | Abstract References ORCID | 173.85 | 207 |
| 11 | Epidemiology of chronic obstructive pulmonary disease: a lit… (10.2147/copd.s32330) | Abstract References ORCID | 171.75 | 194 |
| 12 | Management of COPD in the UK primary-care setting: an analys… (10.2147/copd.s62750) | Abstract References ORCID | 169.15 | 179 |
| 13 | Chronic respiratory diseases and risk factors in 12 regions… (10.2147/copd.s67283) | Abstract References ORCID | 168.78 | 177 |
| 14 | Chronic obstructive pulmonary disease as an independent risk… (10.2147/copd.s6400) | Abstract References ORCID | 168.41 | 175 |
| 15 | The pathophysiology of bronchiectasis (10.2147/copd.s6133) | Abstract References ORCID | 168.23 | 174 |
| 16 | Lung inflammation caused by inhaled toxicants: a review (10.2147/copd.s106009) | Abstract References ORCID | 167.85 | 172 |
| 17 | Defining and targeting health disparities in chronic obstruc… (10.2147/copd.s79077) | Abstract References ORCID | 166.31 | 164 |
| 18 | COPD: balancing oxidants and antioxidants (10.2147/copd.s42414) | Abstract References ORCID | 165.31 | 159 |
| 19 | A telehealth program for self-management of COPD exacerbatio… (10.2147/copd.s60179) | Abstract References ORCID | 165.10 | 158 |
| 20 | Roflumilast: a review of its use in the treatment of COPD (10.2147/copd.s89849) | Abstract References ORCID | 163.85 | 152 |
| 21 | Examining the relationship between anxiety and depression an… (10.2147/copd.s53255) | Abstract References ORCID | 163.21 | 149 |
| 22 | Role of eosinophils in airway inflammation of chronic obstru… (10.2147/copd.s152291) | Abstract References ORCID | 162.99 | 148 |
| 23 | Exacerbation rate, health status and mortality in COPD &… (10.2147/copd.s3385) | Abstract References ORCID | 162.99 | 148 |
| 24 | Prognostic role of neutrophil–lymphocyte ratio and… (10.2147/copd.s141760) | Abstract References ORCID | 162.10 | 144 |
| 25 | Peripheral blood eosinophils: a surrogate marker for airway… (10.2147/copd.s100338) | Abstract References ORCID | 161.88 | 143 |
| 26 | The association between COPD and heart failure risk: a revie… (10.2147/copd.s31236) | Abstract References ORCID | 161.42 | 141 |
| 27 | Is the 1-minute sit-to-stand test a good tool for the evalua… (10.2147/copd.s115439) | Abstract References ORCID | 160.49 | 137 |
| 28 | Roles for proteinases in the pathogenesis of chronic obstruc… (10.2147/copd.s2089) | Abstract References ORCID | 159.53 | 133 |
| 29 | Nasal highflow improves ventilation in patients with COPD (10.2147/copd.s104616) | Abstract References ORCID | 159.29 | 132 |
| 30 | The repeatability of interleukin-6, tumor necrosis factor-&a… (10.2147/copd.s5018) | Abstract References ORCID License | 159.11 | 38 |
| 31 | <p>Activity-related dyspnea in chronic obstructive pul… (10.2147/copd.s188141) | Abstract References ORCID | 158.29 | 128 |
| 32 | Depression and anxiety predict health-related quality of lif… (10.2147/copd.s58136) | Abstract References ORCID | 157.53 | 125 |
| 33 | Pilot study of a cell phone-based exercise persistence inter… (10.2147/copd.s6643) | Abstract References ORCID | 157.53 | 125 |
| 34 | Exacerbation frequency and course of COPD (10.2147/copd.s34186) | Abstract References ORCID | 157.01 | 123 |
| 35 | COPD and osteoporosis: links, risks, and treatment challenge… (10.2147/copd.s79638) | Abstract References ORCID | 156.21 | 120 |
| 36 | Skeletal muscle dysfunction in patients with chronic obstruc… (10.2147/copd.s4480) | Abstract References ORCID | 153.98 | 112 |
| 37 | The association between vitamin D and COPD risk, severity, a… (10.2147/copd.s101382) | Abstract References ORCID | 153.69 | 111 |
| 38 | The use of bupropion SR in cigarette smoking cessation (10.2147/copd.s1121) | Abstract References ORCID | 153.40 | 110 |
| 39 | Clinical characteristics of patients with chronic obstructiv… (10.2147/copd.s83910) | Abstract References ORCID | 153.10 | 109 |
| 40 | Smoking duration, respiratory symptoms, and COPD in adults a… (10.2147/copd.s82259) | Abstract References ORCID | 152.81 | 108 |
| 41 | The one repetition maximum test and the sit-to-stand test in… (10.2147/copd.s91176) | Abstract References ORCID | 152.20 | 106 |
| 42 | Impact of exacerbations on health care cost and resource uti… (10.2147/copd.s36997) | Abstract References ORCID | 151.90 | 105 |
| 43 | Imaging of pulmonary emphysema: A pictorial review (10.2147/copd.s2639) | Abstract References ORCID | 151.28 | 103 |
| 44 | Hypoxemia in patients with COPD: cause, effects, and disease… (10.2147/copd.s10611) | Abstract References ORCID | 150.96 | 102 |
| 45 | Gastroesophageal reflux disease in COPD: links and risks (10.2147/copd.s77562) | Abstract References ORCID | 150.65 | 101 |
| 46 | Improving adherence with inhaler therapy in COPD (10.2147/copd.s14715) | Abstract References ORCID | 149.01 | 96 |
| 47 | Beyond FEV1 in COPD: a review of patient-reported outcomes a… (10.2147/copd.s32675) | Abstract References ORCID | 148.33 | 94 |
| 48 | Influence of diet and obesity on COPD development and outcom… (10.2147/copd.s50111) | Abstract References ORCID | 147.98 | 93 |
| 49 | Role of macrolide therapy in chronic obstructive pulmonary d… (10.2147/copd.s681) | Abstract References ORCID | 147.98 | 93 |
| 50 | Once-daily NVA237 improves exercise tolerance from the first… (10.2147/copd.s32451) | Abstract References ORCID | 147.64 | 92 |